Ford CE - Search Results

1

A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models.

Cortesi M, Liu D, Yee C, Marsh DJ, Ford CE. Cortesi M, et al. Among authors: ford ce. Sci Rep. 2023 Sep 22;13(1):15769. doi: 10.1038/s41598-023-42486-3. Sci Rep. 2023. PMID: 37737283 Free PMC article.

2

I-AbACUS: a Reliable Software Tool for the Semi-Automatic Analysis of Invasion and Migration Transwell Assays.

Cortesi M, Llamosas E, Henry CE, Kumaran RA, Ng B, Youkhana J, Ford CE. Cortesi M, et al. Among authors: ford ce. Sci Rep. 2018 Feb 28;8(1):3814. doi: 10.1038/s41598-018-22091-5. Sci Rep. 2018. PMID: 29491372 Free PMC article.

3

ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.

Liu D, Gunther K, Enriquez LA, Daniels B, O'Mara TA, Tang K, Spurdle AB, Ford CE. Liu D, et al. Among authors: ford ce. Sci Rep. 2020 Aug 17;10(1):13906. doi: 10.1038/s41598-020-70924-z. Sci Rep. 2020. PMID: 32807831 Free PMC article.

4

ROR2 Is Epigenetically Regulated in Endometrial Cancer.

Liu D, Enriquez L, Ford CE. Liu D, et al. Among authors: ford ce. Cancers (Basel). 2021 Jan 21;13(3):383. doi: 10.3390/cancers13030383. Cancers (Basel). 2021. PMID: 33494187 Free PMC article.

5

Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer.

Werner B, Yuwono N, Duggan J, Liu D, David C, Srirangan S, Provan P; INOVATe Investigators; DeFazio A, Arora V, Farrell R, Lee YC, Warton K, Ford C. Werner B, et al. Gynecol Oncol. 2021 Sep;162(3):720-727. doi: 10.1016/j.ygyno.2021.06.028. Epub 2021 Jul 5. Gynecol Oncol. 2021. PMID: 34454680

6

An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles.

Joshi N, Liu D, Dickson KA, Marsh DJ, Ford CE, Stenzel MH. Joshi N, et al. Among authors: ford ce. J Mater Chem B. 2021 Nov 17;9(44):9123-9135. doi: 10.1039/d1tb01837j. J Mater Chem B. 2021. PMID: 34676865

7

ROR1 and ROR2 expression in pancreatic cancer.

Liu D, Sharbeen G, Phillips P; Australian Pancreatic Cancer Genome Initiative; Ford CE. Liu D, et al. Among authors: ford ce. BMC Cancer. 2021 Nov 11;21(1):1199. doi: 10.1186/s12885-021-08952-9. BMC Cancer. 2021. PMID: 34763666 Free PMC article.

8

The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells.

Liu D, Kaufmann GF, Breitmeyer JB, Dickson KA, Marsh DJ, Ford CE. Liu D, et al. Among authors: ford ce. Pharmaceutics. 2022 Apr 11;14(4):837. doi: 10.3390/pharmaceutics14040837. Pharmaceutics. 2022. PMID: 35456672 Free PMC article.

9

Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.

Liu D, Gunther K, Enriquez LA, Daniels B, O'Mara TA, Tang K, Spurdle AB, Ford CE. Liu D, et al. Among authors: ford ce. Sci Rep. 2022 Jun 28;12(1):10918. doi: 10.1038/s41598-022-15043-7. Sci Rep. 2022. PMID: 35764678 Free PMC article. No abstract available.

10

Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival.

Xie T, Dickson KA, Yee C, Ma Y, Ford CE, Bowden NA, Marsh DJ. Xie T, et al. Among authors: ford ce. Cancers (Basel). 2022 Sep 23;14(19):4621. doi: 10.3390/cancers14194621. Cancers (Basel). 2022. PMID: 36230543 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page